Ozempic label, AccessFDA Wegovy label, AccessFDA Glucagon-like peptide-1 receptor: Mechanisms and advances in therapy, Signal Transduction and Targeted Therapy (2024) FDA approves first treatment to reduce risk of serious heart problems specifically in adults with obesity or overweight, U.S
Figure 3 2.2.2 Vagotomy and insights into the microbiotagutbrain axis in Parkinson's The vagus nerve is the tenth cranial nerve
Heart disease Large clinical trials revealed a striking finding: GLP-1 drugs reduce the risk of heart attacks, strokes and cardiovascular death
Edited by Charan P S V V (Founder & Managing Editor), Sona Sunil (Co-Founder & Lead Scientific Outreach) , Saptamita Paul choudhury (Co-Founder & Head Content Writing) , Sanjana Gupta (Strategic Advisor & Editor) - NextGen Biology International Newsletter Core team
GOT1 and GOT2 catalyze the transamination reaction between oxaloacetate and glutamate to produce aspartate and -KG
Alcohol disrupts this balance in two ways: sugary drinks add rapid glucose spikes, while pure alcohol (spirits, wine) can cause delayed hypoglycemiadangerously low blood sugarhours after drinking
